Clinical Trial Update: Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer [NA]

View source ↗

Summary

A clinical trial studying preoperative SABR for early-stage breast cancer has been terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer, Breast Cancer Female | NA | Status: TERMINATED | Results posted: 2020-12-28